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INTRODUCTION 
 Antimicrobial drugs have caused a dramatic change not only of the 
treatment of infectious diseases but of a fate of mankind. Antimicrobial 
chemotherapy made remarkable advances, resulting in the overly optimistic view 
that infectious diseases would be conquered in the near future. However, in 
reality, emerging and re-emerging infectious diseases have left us facing a 
countercharge from infections. Infections with drug resistant organisms remain an 
important problem in clinical practice that is difficult to solve. If an improper 
antimicrobial agent happens to be chosen for the treatment of infection with drug-
resistant microorganisms, the therapy may not achieve beneficial effect, and 
moreover, may lead to a worse prognosis. In addition, in a situation where 
multidrug-resistant organisms have spread widely, there may be quite a limited 
choice of agents for antimicrobial therapy. At present, fewer brand new 
antimicrobial agents are coming onto the market. Considering this situation 
together with the increasing awareness of drug safety, we are now facing a 
situation of severely limited options among antimicrobial agents. 
 
 The history of antimicrobial agents, and thereafter describes resistant 
organisms that have emerged in response to antimicrobial agents and discusses 
practical clues to prevent resistant microorganisms. 
 
HISTORY OF THE DEVELOPMENT OF ANTIMICROBIAL AGENTS 
            Looking back on the history of human diseases, infectious diseases have 
accounted for a very large proportion of diseases as a whole. It was not until the 
latter half of the 19th century that microorganisms were found to be responsible 
for a variety of infectious diseases that had been plaguing humanity from ancient 
days. Accordingly, chemotherapy aimed at the causative organisms was 
developed as the main therapeutic strategy. 
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 The first antimicrobial agent in the world was salvarsan, a remedy for 
syphilis that was synthesized by Ehrlich in 1910. In 1935, sulfonamides were 
developed by Domagk and other researchers. These drugs were synthetic 
compounds and had limitations in terms of safety and efficacy. In 1928, Fleming 
discovered penicillin. He found that the growth of Staphylococcus aureus was 
inhibited in a zone surrounding a contaminated blue mold (a fungus from the 
Penicillium genus) in culture dishes, leading to the finding that a microorganism 
would produce substances that could inhibit the growth of other microorganisms. 
The antibiotic was named penicillin, and it came into clinical use in the 1940s. 
Penicillin, which is an outstanding agent in terms of safety and efficacy, led in the 
era of antimicrobial chemotherapy by saving the lives of many wounded soldiers 
during World War II. 
    During the subsequent two decades, new classes of antimicrobial agents 
were developed one after another, leading to a golden age of antimicrobial 
chemotherapy. In 1944, streptomycin, an aminoglycoside antibiotic, was obtained 
from the soil bacterium Streptomyces griseus. Thereafter, chloramphenicol, 
tetracycline, macrolide, and glycopeptide (e.g., vancomycin) were discovered 
from soil bacteria. The synthesized antimicrobial agent nalidixic acid, a quinolone 
antimicrobial drug, was obtained in 1962. Improvements in each class of 
antimicrobial agents continued to achieve a broader antimicrobial spectrum and 
higher antimicrobial activity.β - lactam antibiotics will be described as an 
example.  
            The β-lactam antibiotics include penicillins,cephems, carbapenems, and 
monobactams. Penicillins were originally effective for Grampositive organisms 
such as S. aureus. Later, to address penicillin-resistant S. aureus which produces 
the penicillin-hydrolysing enzyme penicillinase, methicillin was developed. On 
the other hand, attempts to expand the antimicrobial spectrum yielded ampicillin, 
which is also effective for Gram-negative Enterobacteriaceae, and piperacillin, 
which is effective even for Pseudomonas aeruginosa. 
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 Cephems were developed in the 1960s, and came into widespread use. 
Cephems are classified into several generations according to their antimicrobial 
spectra. 
            First-generation cephems (cefazolin, etc.) are effective only for Gram-
positive organisms and Escherichia coli, although their antimicrobial activity 
against these organisms is potent. 
            Second-generation cephems (cefotiam, etc.) have an extended 
antimicrobial spectrum that covers not only Gram-positive but also Gramnegative 
organisms including other Enterobacteriaceae. 
            Third-generation cephems (ceftazidime, cefotaxime, etc.) have higher 
efficacy for Gramnegative organisms, and some drugs of this generation are also 
effective for P. aeruginosa, although the antimicrobial activity against 
Grampositive organisms is generally lower than that of the first generation. 
Carbapenem is an antibiotic class including panipenem, imipenem and 
meropenem. These drugs are effective not only for Gram-positive and Gram-
negative bacteria but also anaerobes, and their antimicrobial activity is strong.  
            The monobactam  antibiotic aztreonam exerts an antimicrobial effect only 
on Gram-negative bacteria. Continuing improvements have been made for 
antimicrobial agents in various aspects in addition to the antimicrobial spectrum 
and activity. The drugs have been developed to achieve better pharmacodynamics 
including the absorption of oral drugs, concentration in the blood, and distribution 
to the inflammatory focus. In addition, as antimicrobial chemotherapy has been 
established and matured, more importance has been attached to the drug safety. 
Antimicrobial agents that are associated with serious side effects have been 
replaced by other safer drugs. 
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 [82] Quinolone antimicrobials represent an example of drugs with improved 
pharmacodynamics and safety. Nalidixic acid, the first drug of this class, was 
active only against Gram-negative bacteria, and its use was limited to urinary tract 
infections because it achieves only low blood concentrations and poor tissue 
distribution, and was metabolized rapidly in the human body. In contrast, 
norfloxacin, which came to market in 1984, maintains a stable metabolic state and 
exhibits good tissue distribution. Its antimicrobial spectrum is extensive, covering 
both Grampositive and Gram-negative bacteria including P. aeruginosa.  
            Quinolone antimicrobials developed after norfloxacin have been called 
new quinolones, and they have still been key drugs. Levofloxacin is the S-(+) 
enantiomer of the new quinolone ofloxacin. This enantiomer has higher 
antimicrobial activity than that of the other R-(-) enantiomer of ofloxacin, and is 
associated with weaker side effects on the central nervous system, such as 
restlessness and vertigo. Although a large number of companies in various 
countries have competed in the development of newer antimicrobial agents, the 
number of brand new drugs has been remarkably decreasing in recent years, with 
few antimicrobial agents of new classes becoming available. In contrast, 
infectious diseases continue to attack human beings as emerging and re-emerging 
infectious diseases, opportunistic infectious diseases, and infection with drug-
resistant microorganisms that will be discussed in the next section. Effective 
utilization of the current limited options is much more important under the dearth 
of new drugs on the market. 
 The capacity of microorganisms to acquire resistance to antimicrobial 
agents has surpassed our imagination. In some cases, antimicrobial agents 
formerly effective are no longer useful. The history of resistant bacteria will be 
outlined below. 
            S. aureus is the resistant bacterium most familiar in the clinical setting. 
This bacterium rapidly acquired resistance to sulfonamides when they were in use. 
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Penicillin was initially effective to this microorganism, but resistant strains that 
produce penicillinase increased in the 1950s.  
           
 Therefore, penicillinase-stable methicillin was developed in 1960, as 
mentioned previously.         
            However, as early as the following year, 1961, methicillin-resistant  
S. aureus (MRSA) was isolated in the UK.3 Since around 1990, nosocomial 
infection with MRSA became a social problem. During this period, the target of 
new antimicrobial agents including second- and third-generation cephems, shifted 
from Gram-positive to Gram-negative bacteria, and agents with wide spectra but 
weaker activity against Gram-positive bacteria were widely used.                          
   
 MRSA acquires resistance to mostlactam antibiotics through its acquisition 
of the penicillin-binding protein (PBP) 2’ gene; PBP2’ is an enzyme involved in 
cell wall synthesis that has low binding affinity for β-lactam antibiotics. In genetic 
lineage analysis of nosocomial MRSA strains, major nosocomial clones 
throughout the world would converge on only seven types.4 On the other hand, 
community associated methicillin-resistant S. aureus (CAMRSA), which was 
noticed in the US around 1997, is of a different type from nosocomial MRSA. 
        Fortunately, MRSA so far in Japan have responded to glycopeptide 
antibiotics such as vancomycin. However, in the latter half of the 1990s, 
vancomycin-intermediate S. aureus (VISA) was reported in this country. It is 
thought that thickening of the cell wall contributes to decreased sensitivity to this 
drug. On the other hand, vancomycin-resistant S. aureus (VRSA) reported in the 
US seemed to acquire the resistance genes horizontally from vancomycin-resistant 
enterococci (VRE).5 In Japan, there have been no reports of VRSA strains so far, 
partially at least, due to lower detection rates of VRE than those in Western 
countries. Although S. pneumoniae was originally susceptible to penicillin, 
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penicillin-intermediate S. pneumoniae (PRSP) strains were found in the latter half 
of the 1960s, and penicillin-resistant S. pneumoniae (PRSP) strains in the latter 
half of the 1970s.  
 In Japan, PRSP was found in the 1980s, and the detection of PRSP strains 
began to increase around 1990. 
            Frequent use of oral cephem antibiotics seems to be responsible for this 
increase in PRSP. There has also been a remarkable increase in macrolide 
resistance in this species, which seems also due to the frequent use of macrolides 
in this country. Ampicillin was initially effective for Haemophilus influenzae. 
 However, in the 1980s, some of this species were found to produce β -
lactamase, thereby becoming resistant to ampicillin. In 1990s, such _-lactamase-
producing strains decreased in Japan, however, strains that acquired highly 
resistance β -lactam through mutations in PBP genes, increased instead. These are 
called as β-lactamase-negative ampicillin-resistant (BLNAR) strains, and they are 
more common in Japan than in other Western countries. It has been speculated 
that increased use of oral cephem antibiotics is also responsible, similar to the 
situation with PRSP. 
 Although P. aeruginosa are intrinsically resistant to many antimicrobial 
agents, the emergence of P. aeruginosa strains resistant to all of three classes of 
antimicrobials, i.e., carbapenems, quinolones, and aminoglycosides is a recent 
concern. These multidrug resistant P. aeruginosa (MDRP) sometimes seems to 
cause an outbreak in some institutions. MDRP has complex mechanisms of drug 
resistance, including reduced membrane permeability due to decreased outer 
membrane protein (D2 porin), overexpression of efflux pump, mutation of the 
quinolone target (DNA gyrase), production of aminoglycoside modification 
enzyme, and production of metallo-β- lactamase (carbapenem-hydrolysing 
enzyme). 
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            Some resistance genes are horizontally transferred by conjugative 
plasmids. Gonococci used to be susceptible to penicillin and quinolone, but 
currently they are resistant to both agents in Japan. In particular, quinolone had 
been the first-choice drug for gonococcal infection in the 1980s because of the 
potential advantage in the case of co-infection with Chlamydophila. However, 
since almost all the strains have become resistant to quinolones, the 1999 
guidelines declared against the use of quinolone for gonococcal infection. 
 
There are major options exist for the control of bacterial diseases: 
1) Disrupt or halt transfer of bacteria from person to person and from the 
 environment to people 
2) Treat cases of disease with antibiotics 
3) Prevent disease through vaccination or 
  
There are different mechanisms to inhibit the micro organisms growth. 
 
INHIBITORS OF BACTERIAL CELL WALL SYNTHESIS 
 Penicillins 
 Cephalosporins 
 Vancomycin 
 
INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS 
 Aminoglycosides 
 Linazolid 
 Tetracycline 
 Chloramphenicol 
 Erythromycin 
 Clindamycin 
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INHIBITION OF NUCLEIC ACID SYNTHESIS AND FUNCTION 
 Rifampacin 
 Fluoroquinolones 
 Antimetabolites 
 Sulfonamides 
 
AGENTS AFFECTING MEMBRANE PERMEABILITY 
 Polymyxin B 
 Amphotericin B (Anti fugal) 
 
GENETIC STRATEGIES FOR ANTIBACTERIAL DRUG  DISCOVERY 
       This approach provides an advantage compared with classical 
antimicrobial-discovery approaches in which the targets of newly synthesized 
compounds were largely unknown.  Certain microorganisms having a similar 
genetic material sequence like human. These sequences thereby exclude potential 
mechanism-based toxicity of new antibacterial agents.  Without the target identity 
and possible knowledge of genetic material overlap with a human target, it was 
difficult to design the structure-activity relationships of compounds that were 
being developed. 
 The genetic revolution in late 1990s led to identify the new targets that 
could yield new classes of antimicrobial compounds that are vulnerable to the 
present resistance mechanisms.  The availability of complete genome sequences 
allows us to identify proteins that are conserved across the medically important 
pathogens. 
                The first sequence of an entire bacterial genome was determined in 
1995.  By,1997 complete genome sequences were publicly available for at least 11 
organisms, including Esherichia coli, Bacillus subtilis and Saccharomyces 
Cerevisia. Today, more than 100 completed bacterial genomes are available in 
public databases. 
Introduction 
 
 
 
Department of Pharmaceutical Chemistry   9 
 
                 The use of comparative genomics to identify protein targets that are 
candidates for antibacterial drug discovery.  Validate essential proteins as 
antimicrobial targets.  The whole-cell screening strategies are obtained by genetic 
assays. 
Some medically important bacterial pathogens 
Organism Disease 
Genome Reference 
size(Mb) 
Gram-positive cocci 
Staphylococcus aureus 
Skin and wound 
infections,septicemia, 
endocarditis and toxin-
associated syndromes 
2.8 
Streptococcus pneumonia Respiratory 2.2 
Enterococcus saphaecalis 
Bacteria, endocarditis and 
urinary-tract infections 
3.2 
Myoplasma pneumonia Respiratory 0.8 
 
Gram-negative cocci 
Pseudomonas aeruginosa 
Opportunistic disease 6.3 
Haemophilus influenza Respiratory 1.8 
Neisseria gonorrhoea Sexually-transmitted 
disease 
2.2 
Helicobacter pylori Gastrointestinal 1.7 
Samlonella entiriditi Gastrointestinal and 
typhoid 
4.8 
 
Eschericia coli  Gastrointestinal and 
urinary-tract infections 
4.6 
Mycobacterial disease 
Mycobacterium 
tuberculosis 
Tuberculosis 4.4 
 
 
 
TUBERCULOSIS 
  Tuberculosis, one of the most common infections, is caused by 
Mycobacterium tuberculosis. According to the World Health Organization 
(WHO), nearly one third of the world's population has been exposed to the 
tuberculosis pathogen. There are a number of known factors that make people 
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more susceptible to tuberculosis infection worldwide, the most important of which 
is human immunodeficiency virus (HIV). The association of tuberculosis with 
HIV infection is so dramatic that in some cases, nearly two third of the patients 
diagnosed with the tuberculosis are also HIV-1 seropositive[83] . Smoking more 
than 20 cigarettes a day also increases the risk of tuberculosis by two- to four 
times[84] . 
 Unfortunately, Tuberculosis treatment has not seen much progress as 
Mycobacterium tuberculosis (Mtb) is a stubborn pathogen. The available 
treatment options are few depending on a relatively small set of chemotherapeutic 
agents, which includes the widely used front-line drugs like Isoniazid, 
Ethambutol, Rifampicin, and Pyrazinamide[85]. 
 A number of anti-TB drugs are ineffective against TB because of the 
development of resistant strains. The limited effectiveness of current 
chemotherapy stems largely from the lengthy and complicated nature of first-line 
anti-TB drugs. The most problematic issue with the current TB regimen is 
insufficient adherence to the treatment course, attributable to its length, 
complexity and adverse effects, led to difficult- and expensive to-treat multidrug-
resistant tuberculosis (MDR-TB). 
 Treatment for MDR-TB typically requires 18–24 months of combination 
therapy with second-line drugs which are less efficacious, more toxic and 
expensive than the first-line drugs [34]. In few regions, almost 20% of MDR-TB 
cases were classified as extensively drug-resistant tuberculosis (XDR-TB). The 
treatment options for XDR-TB are very limited as XDR-TB bacilli are resistant 
not only to isoniazid and rifampicin, but also to fluoroquinolones and 
aminoglycosides [35]. More recently, another definition of XDR-TB as MDR-TB 
resistant to any fluoroquinolone and at least one of the second-line drugs 
(Capreomycin, Kanamycin and Amikacin) used in TB treatment [36]. There are 
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serious adverse effects with most MDR-TB and XDR-TB drugs, such as 
nephrotoxicity and ototoxicity with aminoglycosides, hepatotoxicity with 
ethionamide and dysglycaemia with gatifloxacin. In few cases, XDR-TB has been 
shown aggressive form of TB, causing very high mortality.  
 
The improvement in TB chemotherapy can be achieved by four primary goals:  
(i)  Shorten and simplify TB treatment  
(ii)  Improve efficacy, safety and reduce long-lasting therapy  
(iii) Develop drugs for HIV-TB co-infection, which can be readily  
 co- administered with antiretrovirals  
(iv)  Shorten therapy of latent TB infection .  
 
 Moreover, to effectively treat and control MDR- and XDR-TB patients, 
physicians and national TB treatment programs require regimens based on safer, 
tolerable and efficacious drugs having new mechanisms of action [86].  
            The Global Alliance for Tuberculosis (GATB) drug development was 
established to address this need. Its top priority is the development of a new agent 
that will shorten the duration of chemotherapy from the current 6 – 8 months to 
two months or less. Also new drugs with activity against Mycobacterium drug-
resistant tuberculosis and latent tuberculosis are needed. 
 WHO has recently launched its innovative “End TB Strategy”[39], 
supporting the TB elimination strategy and the vision of a TB-free world with 
zero death, disease and suffering due to TB. The new strategy clearly supports 
universal access to high-quality MDR-TB diagnosis and treatment. However, 
since the market launch of rifampicin in the early 1960s, no new anti-TB drug has 
been specifically developed until recently. The need for new drugs and regimens 
is obvious[40].  
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 At present, the global TB development pipeline has nine candidates, but a 
key issue is how to develop them simultaneously in combination trials to identify 
the best candidate [41]. In this context, we try here to explore the ubiquitous 
heterocycle, coumarins based scaffold as promising antituberculars. 
 
Literature Review 
 
 
 
Department of Pharmaceutical Chemistry   13 
 
LITERATURE REVIEW 
 2-QUINOLONES 
 Adithya.Adhikari et al.,synthesized a series of 5-(6-substituted -2-hydroxy 
quinolone-3-yl)methylidene[19]. 
              Evaluated for antioxidant, antibacterial and antifungal activity. 
Compounds showed significant antioxidant properties. 
N OH
S
N
O
NH
R
1
R 
 Manish.P.Patel et al., 2014.,synthesized a series of aurones by aldol 
condensation of N(Un)substituted quinolone -3-carbalehyde.[22] 
 Compounds were screened in vitro for their antimicrobial activity against 
bacteria and fungal pathogens and also for their antioxidant properties, Majority  
were active against bacteria and fungi .3k ,3u showed antioxidant activity. 
N
R1
O
R2O
O
R
3
R
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 Thomas kappe et al.,synthesized 3-acyl-4-hydroxy-2(1H)-quinolones With 
nitrogen bases via thermal beckmann rearrangement.(4) 
                                 
 
  Balakrishna Kalluraya et al., synthesized a series of dihydropyrimidine 
derivatives containing quinolones.[44]        
     The synthesized 4–(2-Hydroxyquinoline-3-yl)-5-carboxyethyl-6- methyl–
pyrimidine-2-one were evaluated  for their biological activity.all the synthesized 
compounds showed poor to good biological activity  
 
R = H, CH3, OCH3 R1 = CH3, OC2H5 R2 = H, Ph 
X = O, S                                          
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 Alvie L Davis et al.,synthesized a series of 3-amino-3,4-dihydro-l-
hydroxycarbostyril by reductive cyclizations of the appropriately chloro-
substituted o-nitrophenylalanines,[5] 
 
             The effects of a chloro substituent upon the microbiological activities of 
3-amino-3,4-dihydro-l-hydroxycarbostyril were determined. 7-C1 analog was a 
more effective growth inhibitor than the parent unsubstituted compound.[5] 
 
5-Cl,6- Cl,7- Cl,8- Cl 
                                   
 Xue Wie Liu et al.,synthesized tipifarnib and proved Quinolinone 
derivatives were constructed via a Pd-catalyzed C−H bond activation/C−C bond 
formation/ cyclization cascade process with simple anilines as the substrates[47] 
 
 Kang Zhao et al.,synthesized a series of 3‑Arylquinolin-2-ones. The 
reaction of the readily available N-methyl-N-phenylcinnamamides with 
phenyliodine bis(trifluoroacetate) (PIFA) in the presence of Lewis acids provides 
a general and efficient assembly of a variety of 3-arylquinolin-2-one 
compounds.[48] 
R1=H,Me,OMe,F,Cl,Br,CF3,CO2Me 
Literature Review 
 
 
 
Department of Pharmaceutical Chemistry   16 
 
R2=Me,Bn,ipr,cycloprpylmethyl 
R3=H,R 
 
N O
Ar
-
R
3
R2
R
 
               
 Eswaran Ramachandran et al.,synthesized a series of new 2-oxo-1,2-
dihydrobenzo[h]quinoline-3-carbaldehyde thiosemicarbazones[9] 
            Four new 2-oxo-1,2-dihydrobenzo[h]quinoline-3-carbaldehyde N-
substituted thiosemicarbazone ligands  and their corresponding new cobalt(III) 
complexes have been synthesized, characterized and evaluated for DNA binding, 
antioxidant and cytotoxic activity. The compounds showed significant antioxidant 
activity and higher cytotoxic activity with lower IC50 values indicating their 
efficiency in killing the cancer cells even at very low concentrations. 
                      
 
 Manish P Patel et al.,synthesized a  new series of 12 derivatives of 4-
pyrazolyl-N-arylquinoline-2,5-dione were synthesized by one pot base catalyzed 
cyclocondensation reaction[12]. 
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            All the compounds were characterized by elemental analysis and  
screened, for their antimicrobial activity against six bacterial pathogens, Some of 
the compounds were found to be equipotent or more potent than commercial 
drugs, against most of the employed strains, as evident from the screening 
data.(10) 
N O
O
R
1
R
2
N N
Cl CH3
R2
R
 
 
 
 
 Stephen heeb reviewed an article quinolones to antibiotics and 
autoinducers[63] 
 
Literature Review 
 
 
 
Department of Pharmaceutical Chemistry   18 
 
  A wide variety of quinolone compounds have been discovered, several of 
which possess medicinally interesting properties ranging from antiallergenic and 
anticancer to antimicrobial activities. 
 
 
         
  BENNIKALLU HIRE MATHADA et al., synthesized some of 5-
Substituted-3-phenyl-Nb- (Substituted-2-oxo- 2H-pyrano [2,3-b]quinoline-3-
carbonyl)- 1H-indole-2-Carboxyhydrazide. 
  All the newly synthesized compounds were confirmed by spectral data 
and have been screened for their antibacterial activity, antifungal activity and 
antituberculosis activity and major compoungs showed promising 
antimicrobial,antifungal and antimycobacterial  activity[53] 
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N O
NH NH
O O
N
O
R
 
 
 
 N D Pradeep singh demonstrated a  new class of carboxylate and sulfonate 
esters of 1-hydroxy- 2(1H)-quinolone as nonionic photoacid generators 
(PAGs).[64] Sulfonates of 1-hydroxy- 2(1H)-quinolone were found to be stable 
at room temperature Irradiation of carboxylates and sulfonates of 1-hydroxy-
2(1H)-quinolone in aqueous methanol (l_310 nm) generated the corresponding 
carboxylic and sulfonic acids in good quantum yields. 
 
                                                  
N O
O
O
R
  
    R1=5a=CH2CH2C10 ,5b=C6H5  5c=p-MeC6H4,  5d=p-MeOC6H4,   5e=p-
NO2C6H4   
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 Ankur Vaidya et al., reviewed on current developments of quinoline-based 
anticancer agents. [65] 
            Synthesized compounds 4,5)thieno(2,3)-quinolone derivatives  Compound  
onleft showed best anticancer activity while compound on right shows least 
anticancer activity against. 
                 
 
 M B Deshmukh et al.,synthesized a series of N’-Acetylehydrazido 
qumoIin-2(lH) ones 
             
 The synthesized compounds were screened for their antitumor activity [54] 
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LITERATURE REVIEW OF SCHIFF BASE 
Antimicrobial activity 
 Creaven B S et al., 2010 synthsized a series of quinolin-2(H)-one-triazole 
derived schiffs base. 
 A series of quinolin-2(H)-one-triazole derived schiffs base ligand were 
synthesized by  aldol condensation of 4-amino-1,2,4-triazole with N-substituted-3-
formyl-4-hydroquinolin-2-(1H)-one. The synthesized compounds have been tested 
for their antimicrobial activity against gram positive, gram negative bacteria and 
fungal strains. 
 
R = H, CH3, C2H5 
 Pulin nath et al.,synthesized a series of  Co(II), Ni(II), Cu(II) and Zn(II) 
complexes of Schiff bases of N'-[(E)-(2-hydroxyquinolin-3-yl)methylidene]-2-[(4-
methyl-2-oxo-2H-chromen-7-yl)oxy] acetohydrazide(OHQZ)[33] 
 A series  of  Co(II), Ni(II), Cu(II) and Zn(II) complexes of Schiff bases of 
N'-[(E)-(2-hydroxyquinolin-3-yl)methylidene]-2-[(4-methyl-2-oxo-2H-chromen-
7-yl)oxy] acetohydrazide(OHQZ) have been screened for their antibacterial, 
antifungal and DNA cleavage studies 
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 M.R.Pradeep kumar synthesized a series of substituted hydrazides yielded 
the novel schiffs bases of quinolones .[11] 
             All the synthesized compounds were screened for invitro antifungal 
activity by serial dilution method. The preliminary antifungal activity screening 
result of these compounds depicted them as potential antifungal leads endowed 
with moderate to excellent activity. 
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 Jayashree B.S et al.,synthesized a series a 10compouds of schiffs bases of 
7-amino-4-methyl carbostyrils b Conrad- limpach synthesis .[41] 
             They all were evaluated for their antibacterial activity by agar diffusion 
method.out of  ten, four compounds  showed  good antibacterial activity against 
both gram positive and gram negative organisms. 
N
H
O
CH3
N
N
R
3
R
4
R
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 Abishek Kumar et al., A series of novel substituted 3-acetyl-1 
(benzylideneamino) quinolin-2(1H)-one (1-12) have been synthesized by 
condensing different substituted3-acetyl-1-amino-quinolin-2-one and aromatic 
aldehydes in alcohol medium[68]. 
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 The synthesized compounds were screened for their antimicrobial, 
antioxidant and cytotoxicity activities. And concluded that most of the synthesized 
compounds showed good antimicrobial activity and few compounds showed good 
antioxidant and cytotoxicity activity. 
 
                           
N O
N
COCH3
R
 
R: H, 6-NO2, 6-Cl, R1: 3-NO2, 3,4,5-OCH3, 4-CH3, 4-OH, 2-Cl, 2-NO2 
 
 Redha I. Al-Bayati et al.,synthesized a new schiffs base 1-[(2-hydroxy-
benzylidene)-amino]- 4,7-dimethyl-6-nitro-1H-quinolin-2-one and screened for its 
antimicrobial activity.[62] 
            1-amino-4-7-dimethyl-6-nitro-1H-quinoline-2-one was reacted with 
salicyaldehyde to synthesize the corresponding Schiff base. and resulted that 
synthesized compounds showed no activity. 
 
N
O
N
+
O
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 K Siddapa et  al ., synthesized a new complex of 3-[(2-hydroxyquinoline-
3ylmethylene)-amino]-2-methyl-3-H-quinazolin-4-one[67] 
             The synthesized compounds were characterized by spectroscopic methods 
and tested for their antimicrobial activity against selected bacteria and fungi and 
found that metal complexes are much more potent against antimicrobial pathogens 
in comparision to free Schiff base ligand. 
 
 Anu Kajal et al.,reviewed various Schiff  bases and those compounds were 
evaluated for their various biological activities such as anti-inflammatory, 
analgesic, antimicrobial, anticonvulsant, antitubercular, anticancer, antioxidant, 
anthelmintic, antiglycation, and antidepressant activities[31] 
     
Antitumor activity 
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 Shreedhar D. Dhumwad et al., synthesized a  series of La(III), Ce(III), 
Pr(III), Nd(III), Sm(III), Eu(III), Gd(III) and Dy(III)complexes have been 
synthesized with Schiff bases derived from 4-aminomethylcarbostyril and 
substituted salicylaldehyde.and screened for their antitumour activity.[8] 
 
 In that biological studies, some of the compounds have shown promising 
results. The in vitro antitumor study of the complexes reveals that the activity of 
Lanthanide(III) complexes increases at lower concentrations. 
 
   Xian-li Ma et al., designed and synthesized a set of 2-oxo  quinoline  
aminophosphonate by kabachnik-fields reaction.[81] 
 The  synthesized a set of 2-oxo  quinoline  aminophosphonate compounds 
were evaluated  for their  antitumor  agents.the compounds were found to exhibit a 
novel antitumor activity. 
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5a=R1=R2=H,5b=R1=CH3,R2=H,5c=R1=OCH3,R2=H,5d =R1=R2=CH2OCH2 
 
 Karupannan natarajan et al.,synthesized a series of novel binuclear Pd(ll) 
complexes of 2-oxoquinoline-3- carbaldehyde Schiff  bases.[36] 
            The newly synthesized  novel binuclear Pd(ll) complexes of 2-
oxoquinoline-3- carbaldehyde Schiff  bases were characterized by elemental 
analysis ,spectroscopic technique and and its catalytic efficiency was tested for N-
arylation of imidazole. 
 
(Y = O or S; R = H or CH. 
 
 
Antimycobacterial activity 
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 Mustapha C. Mandewale et al.,synthesized a new series of 6-fluoro-2-
hydroxyquinoline-3-carbaldehyde.[35]          
 The newly synthesized schiffs bases and their Zn(ll) and Cu(ll) complexes 
were evaluated for their anti-tubercular activity.Zn(ll)metal complex showsbetter 
fluorescence as well as anti-tubercular activity than Cu(ll).         
    
  Santhosh kokate et al., 2016 synthesized a series of hydrazone derivatives  
2-(2-oxo-1,2,3,4-tetrahydroquinoline-7-yloxy)acetohydrazide.[10]          
            They were prepared from 7-hydroxy-3,4-dihydroquinolin-2(1H)-one as 
starting material. Then the condensation of 2-(2-oxo-1,2,3,4-tetrahydroquinoline-
7-yloxy)acetohydrazide with different o-hydroxyaldehyde derivatives yielded into 
hydrazone derivatives . These hydrazone ligands were complexed with Zn (II) 
yielded complexes and screened for their antitubercular activity.synthesized 
compounds 6c, 6e, 6h proven as efficient antitubercular agent.  
 
Antioxidant Activity  
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  Xianghui Yi et al aynthesized a series of 2-oxo-quinoline-3-carbaldehyde 
derived Schiff  bases[48] . 
            The compounds were synthesized based on the 2-oxo-quinoline structure 
core as novel antioxidants. The synthesized compounds were evaluated for their 
antioxidant activity. The results showed that IC50 of most compounds were lower 
than standard value 10 mg/mL, indicating good antioxidant activities of these 
compounds. 
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PURPOSE AND PLAN OF WORK 
Infectious diseases are most devastating diseases all over the world. They 
are mainly caused by various infectious micro-organisms. All these infections may 
cause illness and in some cases lead to death of patients. There are many ways to 
get the infectious diseases, but in all the cases we are not able to prevent the 
infections that spread. Every year millions of people are prone to infectious diseases 
and death rate is also getting fluctuation due to the intensity of easily spreading 
character of the microorganism. 
To overcome this all the major pharmaceutical companies are involved in 
extensive research work to generate powerful antibodies against the drastic disease 
causing agents. Although there are potent antibiotics are present in market. But day 
to day there is a need for new potent antibiotics, because the microorganism are 
getting  resistant to the drugs by adopting themselves to withstand the potency of 
the drug ,by mutation, membrane permeability and spore formation. 
The spread of drug-resistant TB is a man-made tragedy, caused by 
inadequate or incomplete treatment for decades, old drug regimen that takes atleast 
six months to cure TB. Drug resistant strains emerge when bacteria are sporadically 
exposed to existing drugs, or when patients are unable to complete the lengthy and 
burdensome treatment. 
Multidrug-resistant TB(MDR-TB)is defined by resistant to atleast two of 
today’s four standard first-line drugs. The World Health Organization (WHO) 
estimates that there are nearly a half-million new cases of MDR-TB each year. 
These cases are difficult to manage and have much lower cure rates. For MDR-TB 
patients, treatment can take upto 2 years, with second line drugs that are more 
expensive, do not always work, and have significant side effects. 
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However, only a limited effort has been made to develop new active 
chemical entities or rapid diagnostic tests, and their relevance to the global TB 
control has been questioned.  
 Combinations of  two or more active moieties into one is a common 
procedure for getting the synergistic effect to enhance the drug activity with less 
dose of drug. 
Quinolones is a most important heterocyclic moiety which exhibits 
remarkable pharmacological activities. Literatures also indicates that the 
compounds having quinolone nucleus have a wide range of therapeutic uses that  
include anti-bacterial , anti-inflammatory ,antiviral, anti-tubercular , anticancer 
activities. 
3-formyl-2-quinolone and substituted 3-formyl-2-quinolones ,isoniazid 
based Schiff  bases have been reported to posses antimicrobial properties, hence the 
synthesized compounds were screened for their in-vitro antimicrobial activity 
against selected strains of gram positive , gram negative bacteria and fungi and for 
their  antimycobacterial activity against strain mycobacterium tuberculosis H37RV.  
The present work consists of the following different stages:- 
Phase I   :  Literature review 
Phase II  :  Synthesis of various Schiffs bases                                          
Phase III :  Spectral studies of their synthesized compounds 
Phase IV :  Antimicrobial screening of synthesized compounds  
                     Antimycobacterial studies                                          
  Antibacterial studies 
  Antifungal studies 
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CHEMISTRY 
VILSMEIR HAACK REACTION [1] 
           In 1927 Vilsmeier and Haack observed that N-methylformanilide can 
formylate aniline derivatives in the presence of POCl3.1 Later the reaction was 
extended using simple formamide derivatives like N,N-dimethylformamide, N-
formylpiperidine, N-formylmorpholine etc. to formylate electron rich aromatic 
and aliphatic substrates, and these types of reactions are known as Vilsmeier-
Haack reactions.2 A Vilsmeier- Haack reagent 3 is produced when a disubstituted 
formamide or amide, typically N,N-dimethylformamide (DMF) 1 is treated with 
an acid halide, frequently phosphorous oxychloride, though to a lesser extent, 
oxalyl chloride . 
 
Synthetic Method 
 There have been a number of practically important routes to synthesise of 
2-chloroquinoline-3-carbaldehydes and one among them is Vilsmeier-Haack 
reaction of acetanilides 
 
1.  Vilsmeier-Haack reaction 
            2-Chloroquinoline-3-carbaldehydes 2 were synthesized from acetanilides 1 
via a Vilsmeier-Haack reaction either by traditional methods or by microwave or 
ultrasonic irradiation.  
Mechanism: 
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QUINOLONES 
 Quinolones are molecules structurally derived from the hetero bicyclic 
aromatic compound quinoline, the name of which originated from the oily 
substance obtained after the alkaline distillation of quinine (Gerhardt, 1842). Since 
the isolation of quinine from Cinchona bark in 1811, many other quinoline 
derivatives have been isolated from natural sources. In particular, 2-hydroxy 
quinoline and 4-hydroxyquinoline, which predominantly exist as 2(1H)- 
quinolone and 4(1H)-quinolone, respectively, and form the core structure of many 
alkaloids, were isolated from plant sources. Several different animal and bacterial 
species also produce compounds of the quinolone class. 
 It is a 2-ring condensed heterocyclic compound containing N as hetero 
atom,and contains several positions that can be replaced by arbitrary substituent 
groups and is used as a chemical building block, scaffold, fragment, and 
pharmacophore in drug design or discovery.2 quinoline is an organic compound 
related structurally related to quinolone.It is the majority tautomer in equilibrium 
with 2-quinolinol.The compound can be classified as a cyclic amide,and as such is 
used as a isostere for peptides and other pharmaceutically-inspired targets.The 
isomer 4 quinoline is the parent of a large class of quinolone antibiotics. 
N
H
O
 
Other names: 
                      Carbostyril 
                      1,2-dihydroxy-2-oxoquinoline 
                      1H-quinolin-2-one 
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2 quinolone(right)and its tautomer 2-hydroxyquinoline (left) 
Chemical reactivity[6] 
 It is evident from the topography of 4-hydroxy-2(1H)- Quinolone.That it 
possesses both electrophilic and nucleophilic properties. The third position in the 
4-hydroxy- 2(1H)-quinolone ring is highly activated, because of the influence of 
the hydroxyl group with electron-donating properties and electron-withdrawing 
effects of carbonyl oxygen atom at the second place. There is a conjugation of p-
electrons from  the double bond and lone p-electron pairs from oxygen atom. 
These factors make the third position in the quinolone ring very convenient for 
many reactions. Thus reactions like coupling and halogenation reactions have 
taken place readily at such carbon. Recently Michael type addition was also 
described. The oxygen atom of the hydroxyl group however remains the main site 
for attack by acylating and alkylating agents. It seemed that hard nucleophiles 
attack preferentially oxygen atom and somewhat nitrogen atom, while the soft 
ones attack preferentially the carbon atom 
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SYNTHESIS [6] 
BIOSYNTHETIC PATHWAY 
 Biosynthesis of 4-hydroxy-2(1H)-quinolone 1 involves benzalacetone 
synthase from Rheum palmatum efficiently catalyzed the condensation of 
anthraniloyl-CoA 2 with malonyl- CoA 3 to produce 4-hydroxy-2(1H)-quinolone, 
a novel alkaloidal scaffold produced by a type III polyketide synthase (PKS). 
 
 
SYNTHETIC PATHWAY  
 There are several methods for the synthesis of 4-hydroxy- 2(1H)-
quinolone . The following are some of the methods which have been used to 
prepare 4-hydroxy- 2(1H)-quinolone. 
 
1) The reaction of 2-aminoacetophenone  with acylating agents  such as 
phosgene, dimethylcarbonate, or  diethylcarbonate in the presence of 
stoichiometric amount of base in anhydrous toluene afforded 4-hydroxy-2(1H)-
quinolone 1 in variable yields. It was found that sodium hydride was a more 
effective base than sodium ethoxide. 
      
 
2)  Condensation of aniline 6 with malonic acid 7 in the presence of a mixture 
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of anhydrous zinc chloride and phosphorus oxychloride as the condensing agent 
furnished. This environmentally unacceptable procedure suffers from many 
disadvantages like long reaction period, use of dehydrating agents (ZnCl3) and 
hazardous reagent (POCl3). Recently, it was found that, the yield was improved to 
be carried out under microwave condensation in the presence of N,N-
dimethylformamide, which acts as an energy transfer agent and homogenizer to 
increase the reaction 
 
3) Intramolecular cyclization of malonic acid monophenyl amide  to form 4-
hydroxy-2(1H)-quinolone  is a convenient procedure; the crucial problem 
to be solved is to reduce or eliminate the decarboxylation of the 
intermediates. Thus, Eaton’s reagent (phosphoric anhydride and methyl 
sulfonic acid)  or polyphosphoric acid (PPA)  was chosen as cyclization 
reagents in mild reaction condition  The synthesis of 4-hydroxy-2(1H)-
quinolone 1 is also observed via cyclization of N,N-diphenyl malonamide  
in the presence of polyphosphoric acid (PPA) at 140–150° C. ) 
 
A=Eatons reagent,70°c  ,B=PPA,1400 C 
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5)  Shobana et al. have described an efficient procedure for the synthesis of 4 
hydroxy quinolone  via the cleavage of 4-allyl quinoloneyl ether  or quinoloneyl 
ethyl carbonate  using a catalytic amount of hydrogen sodium telluride in acetic 
acid and ethanol. 
 
 
6)  Short term (30 min) boiling of the ethyl ester of 4-morpholino- 2-oxo-1,2-
dihydroquinoline-3-carboxylic acid 11 in concentrated hydrochloric acid afforded 
4-hydroxy-2(1H)-quinolone. 
 
7)  Aminolysis of oxazoloquinolone  with aniline  under heating in acetone for 
two hours gave 4-hydroxyquinolone 1 in 83% yield  
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8)  Similarly, oxazoloquinolone  was easily hydrolyzed by a mixture of 
acetone/water at room temperature to give 4- hydroxyquinolone 1 in 90% yield  
 
 
9)  4-Amino-2-hydroxyquinoline on heating with aqueous potassium 
hydroxide was smoothly hydrolyzed and converted into 4-hydroxyquinolone 
 
 
10)  The reduction of ethyl 3-(2-nitrophenyl)-3-oxopropanoate 13 with 
hydrazine hydrate and 10% Pd/C in ethanol at 230c and subsequent cyclization 
lead to the formation of quinolone  in 86% yield . Also, this reduction can be 
successfully carried out by means of hydrogen in the presence of platinum black 
catalyst  
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REACTIONS OF 2-QUINOLONES  
Reactions involving cleavage of lactam ring 
 Reaction of  with two equivalents of cerium(IV) ammonium nitrate (CAN) 
in methanol at room temperature afforded methyl-N-(2-methoxycarbonylphenyl) 
oxalamate  as the sole product in 94% yield  
 
Reactions involving carbon–carbon bond formation 
C-C Bond formation 
C3-Allyation reaction. 
 The allyation of 4-hydroxy- 2(1H)-quinolone 1 is an important strategy for 
the formation of C–C bonds in organic synthesis. Synthesis of allyl and benzyl-
substituted 4-hydroxy-2(1H)- quinolone compounds. Activator-free and one-pot 
C-allylation of 4-hydroxy- 2(1H)-quinolone  by simple palladium catalyst in water 
is now a well-documented process . Palladium-catalyzed allyation of using 
cinnamyl alcohol directly gave the corresponding mono- and diallylated products 
 
 
 
C3-Benzylation. 
 Iridium catalyzed alkylation of 4-hydroxy- 2(1H)-quinolone  with benzyl 
alcohol  under solvent free thermal condition afforded the corresponding 3-
benzyl-4- hydroxyquinolin-2(1H)-one  
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Propargylation and allenylation 
 Propargylation of 4- hydroxy-2(1H)-quinolone  with propargyl bromide  in 
the presence of anhydrous potassium carbonate, under reflux conditions for 12 h 
in acetone, afforded a mixture of O,O-dialkylated quinolone and C,C,O-
trialkylated quinolone. 
 
 
Olefination 
 One of the most successful strategies for constructing 3-benzylidene 
quinolone in only one diastereoisomeric form (Z) is the Knovenagel condensation. 
Heterocondensation reaction between 4-hydroxy-2(1H)-quinolone 1 and 
benzaldehyde in pyridine   under gave (Z)-2,4-dihydro-3-benzylidenquinolin-2,4-
dione. 
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 Michael addition of  with the sodium salt of 1,2-naphthoquinone-4-
sulfonate in  alcoholic sodium hydroxide at 40°C by crushing in a mortar or 
traditional heating gave 3-(3-hydroxy- 4-oxonaphthalen-1-ylidene)quinoline-2,4-
dione  
 
 
Reactions involving carbon-heteroatom bond formation 
 C–N Bond formation 
 Coupling reactions.  
 3-(2-Phenylhydrazono)quinoline- 2,4(1H,3H)-dione  was prepared by 
coupling of basic solution (sodium acetate) of 4-hydroxy-2(1H)-quinolone  with 
diazotized aniline . 
 
Nitration reaction. 
 Nitration of  with neat nitric acid or a mixture of glacial acetic acid and 
concentrated nitric acid afforded 4-hydroxy-3-nitroquinolin-2(1H)-one 3 
 
Formation of substituted amine (Amination). 
 A simple and facile amination of  with equimolar amounts of aniline (neat) 
or p-anisidine (in Ph2O) afforded 4-anilino-2-quinolinone a or 4-methoxy 
derivative , respectively  
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 Stadlbauer and Kappe described the condensation of 1 with 
phenylmethanamine in various solvents under reflux condition which gave the 4-
(phenylamino)quinolin-2(1H)-one 
 
Formation of azide 
 The formation of 3-diazo-1H-quinolin- 2,4-dione  is observed when 4-
hydroxy-2(1H)-quinolone  is reacted with mesyl azide  in ethanol in the presence 
of triethyl amine. 
 
Formation of oxime.  
 The main method for the synthesis of the quinolone oxime  is based on the 
reaction of sodium nitrite with  in the presence of acetic acid  or hydrogen 
chloride.  
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C–S Bond formation 
Sulfides (Thioethers) formation. 
 Treatment of 4-hydroxy-2(1H)-quinolone 1 with diaryl disulfides  in 
dimethylformide in the presence of potassium carbonate yielded 4-hydroxy-1-
methyl-3-(2,4,5-trichlorophenylthio)- 2(1H)-quinolone  
 
 
Thionation reaction. 
 4-Hydroxy-2(1H)-quinolinone  reacts with dimethylsulfoxide  in acetic 
anhydride at 100 _C to afford 3-dimethylsulfonioquinoline-2,4-dionate  as the 
main product . 
 
 
C–O Bond formation 
Esterification. 
  The direct esterfication of 4-hydroxy- 2(1H)-quinolone  with acetic 
anhydride  using triethylamine , pyridine  or acetic acid afforded 4-
acetoxyquinolin-2-one  in good yield . 
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  The esterification of 4-hydroxy-2(1H)- quinolone 1 with 2-furoyl chloride  
in pyridine and dichloromethane afforded 2-oxo-1,2-dihydroquinolin-4-yl-furan- 
2-carboxylate  as human rhinovirus 3C protease inhibitors  
 
 
 4-Allyloxyquinolone  was obtained by the reaction of 4- hydroxy-2(1H)-
quinolone  with allylic bromide  and silver carbonate in benzene for 72 h at room 
temperature. 
 
 
 Acylation of 4-hydroxyquinolin-2-(1H)-one  with undec- 10-enoyl 
chloride afforded 2-oxo-1,2-dihydroquinolin-4- ylundec-10-enoate . 
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Glucosylation reaction.  
 Selective glucosylation of 1 into 4-(b-D-glucopyranosyloxy)quinoline-
2(1H)-one was proceeded  via treatment of 1 with tetra-acetobromo-a-D-glucose  
in combination with cesium carbonate in acetonitrile at room temperature to give 
4-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyloxy)- quinolin-2(1H)-one in 74% 
yield 
 
Hetero ether formation 
Sulfonate ether formation.  
 Two groups have reported the one step formation of 4-(p-
toluenesulfonyloxy)-2(1H)-quinolone via tosylation reaction of 4-hydroxy-2(1H)-
quinolone 1 with tosyl chloride  in pyridine and 4-(N,N-dimethlyamino)pyridine 
or triethylamine in dichloromethane  at room temperature  
 
 
Phosphorylation reaction 
 A series of new piperazine phosphoramide derivatives of 4-
hydroxyquinoline  were synthesized through a facile phosphorylating reaction 
starting from 4-hydroxy-2(1H)-quinolone  and various phosphorylating agents in 
the presence of triethylamine at room temperature  
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Bromination.  
 Bromination of 4-hydroxy-2(1H)-quinolone 1 with bromine in formic acid, 
acetic acid  or phosphorus oxytribromide  yields 3,4-dibromo quinoline 86 . 
 
 Gaston have repeated this reaction in formic acid, but isolated only 3-
bromo-4-hydroxy-2(1H)-quinolone , the structure of which was firmly established 
by conversion into the known 3-bromo-2,4-dimethoxyquinoline 
 
Chlorination 
 Chlorination of 4-hydroxy-2(1H)-quinolone with phosphorous oxychloride 
under reflux condition afforded 2,4-dichloroquinoline 88 in good yield . Also, 
microwave-assisted reaction using chlorophosphonium salt was examined for this 
reaction, and it shortened the reaction time (5 min) as compared with a thermal 
reaction  
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Iodination 
                  Iodination of 4-hydroxy-quinolin-2(1H)- one  with iodine in aqueous 
dioxane afforded 4-hydroxy-3- iodoquinolin-2(1H)-one  in 83% yield 
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SCHIFFS BASE 
INTRODUCTION[69,70,80] 
N
R1
R2 R3 
R1, R2= alkyl,aryl or H 
R3= alkyl ,aryl 
General structure of a Schiff base 
 Schiff bases are biologically as well as synthetically important nitrogen 
containing compounds having azomethine group (-CH=N-) and are formed by 
condensation between primary amines and carbonyl compounds.Schiff bases 
exhibits a broad range of biological activities including antifungal, antibacterial, 
antimalarial, antiproliferative, anti-inflammatory, antiviral,anti-tubercular and 
antipyretic properties  
 Schiff bases have a large number of synthetic uses in organic chemistry. 
Acylation of Schiff bases by acid anhydrides, acid chlorides and acyl cyanides is 
initiated by attack at the nitrogen atom and leads to net addition of the acylating 
agent to the carbon-nitrogen double bond. Reactions of this type have been put to 
good use in natural product synthesis.  
            Schiff bases appear to be an important intermediate in a number of 
enzymatic reactions involving interaction of an enzyme with an amino or a 
carbonyl group of the substrate. One of the most important types of catalytic 
mechanism is the biochemical process which involves the condensation of a 
primary amine in an enzyme usually that of a lysine residue, with a carbonyl 
group of the substrate to form an imine, or Schiff base. 
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GENERAL METHODS FOR THE FORMATION OF C=N BONDS 
a)  Amine carbonyl condensations: 
 The classic method for the introduction of the carbon nitrogen double bond 
into the molecule involves the condensation of aldehydes and ketones with a 
variety of amino compounds ( amines, hydroxylamines, hydrazines) followed by 
elimination of elements of water to give corresponding azomethines. 
O
R1
R2
+ R3 NH2 N
R1
R2 OH R3
H
N
R1
R2 R3
+ H2O
R1,R2= H, alkyl,aryl 
R3= alkyl, aryl, OH,OR,NHR 
b) Condensation reaction involving active methylene compounds: 
 Aromatic nitroso compounds undergo base catalysed condensation with 
active methylene compounds to give intermediate adducts (hydroxylamine 
derivatives ) which can be dehydrated to azomethines. 
N O
Ar
+ R2
R1
base -H2O
N
Ar
R2
R1
R2
R1
N
Ar
OH
 
c)   Dehydrogenation (oxidation) of amino compounds to azomethines: 
 The dehydrogenation of primary or secondary alkylamines over nickel, 
platinum, chromium catalysts or in contact with sulphur, or selenium gives 
acceptable yields of corresponding azomethines. 
 Reagent used: Hydride transfer reagents (diazonium fluoroborates, trityl 
perchlorate) 
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N
R4
R3R1
R2
N
+
R4
R3R1
R2
 
d) Elimination reaction leading to azomethines: 
 Thermal and base catalysed elimination of substrates derived by 
electroplilic attack (halogenations, nitrosation, nitration, sulphonation) at the 
nitrogen atom of primary and secondary alkylamines. 
X
R3R2
R1 H
base or heat
-HX
N
R3
R1
R2
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GENERAL REACTIONS OF SCHIFF BASES 
a)  Reaction with electrophiles  
 Electropliles attack predominantly at nitrogen atom in the azomethines. 
i) Halogenation 
 Halogens are reported to add in a 1,2-fashion to the carbon-nitrogen 
double bond in N-arylaldimines. The product of the reaction of benzylidene 
aniline with bromine in carbon tetrachloride is formulated as an N-bromoiminium 
bromide. 
Ph
N Ph + Br2 Ph
N
+
Ph
Br
Br
-
+
 
ii) Alkylation 
 Direct alkylation of N-alkyl aldimines and ketimines occurs at the nitrogen 
atom to give corresponding iminimum salt. N-alkylation of N-monosubstituted 
hydrazones has been applied intramolecularly providing a general route to 
pyrazolines. 
R1
R2
X
N
R3
NH
R4
N
N
R4
R2
R1 R3
- HX
 
iii) Acylation: 
 Acylation of Schiff’s base by acid anhydrides, acid chlorides and acyl 
cyanides is initated by attack at the nitrogen atom and leads to net addition of 
acylating agent to the carbon nitrogen double bond. 
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N
H
ArPh
+ CH3
O
CHCl 2 Et3N
N
+
Ar
H Ph
CCl2
O
-
N
ClCl
O
Ar
Ph  
b)  Reaction with nucleophiles 
 Nucleophilic reagents attack azomethines at imidyl carbon atom. 
1) Alkoxide adds to Schiff’s base giving corresponding α- alkoxyamino 
 compounds. 
N
O
R
R
NOC2HCOPh
MeOH
N
PhOCHC2ON
MeO
O R
R
 
2) Reaction with Grignard reagents: Schiff base lacking hydrogen atoms α to 
the carbon nitrogen double bond react with Grignard reagents to give adducts 
which on hydrolytic workup afford secondary amine in excellent yield. 
N
CH3
R1
R2
R
4
MgX
N
XMg
R3R4
R2 R1
NH
R3
R4
R2 R1
 
3) Reaction with active methylene compounds: Schiff base react readily with 
active methylene compounds to give adducts which tend to eliminate the elements 
of an amine affording the corresponding alkene. 
N
H
ArR
+ X
Z
X
Z Ar
NH R
-RNH2 Z
XAr
H
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c)  Oxidation  
 Oxidation of Schiff base with a peroxy acid results in cleavage of carbon 
nitrogen bond to give a carbonyl compound and a nitroso compound. On the other 
hand oxidation using peroxy acid at low temperature (00 C) affords an excellent 
synthetic route to oxaziridines. 
N
R3
R1
R2
R
4
COOH O
N
R3R1
R2  
d) Reduction  
 Alkali metals in inert solvents such as ether or toluene tend to promote 
reductive dimerization by a radical coupling mechanism to afford diamino 
compound as a major product.Metal proton reagents (sodium, sodium amalgam, 
magnesium, aluminium in ethanol etc.) smoothly reduce Schiff base to 
corresponding amines. 
R1
N
Ar
R2
Ph
N
-
Ar
-
R1 Ph
R2
NH
Ar
R1 R2
Ph
NH
Ph
R2
Ar R1
NH
Ar
R1
Ph
R2
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MECHANISM 
 Imines are prepared by a reaction between a carbonyl compound and a 
primary amine. If the imine contains a hydrogen atom, it is unstable and usually 
cannot be isolated. However when the imine contains aromatic group on the 
nitrogen, the resulting imine is stable and can be isolated. The products are called 
Schiff  base.    
Step 1: 
O
R1
R2
+ NH2 R3 N
+
H
R3
H
R2
O
-
R1
N R1
OH
R2
H
R3
..
 
 Nucleophilic addition of the amine to the carbonyl compound followed by 
transfer of a proton from nitrogen to oxygen leads to the formation of tetrahedral 
carbinolamine intermediate. 
Step 2: 
 Elimination of water to gives the corresponding azomethines. 
N R1
OH
R2
H
R3
N
R3
R2
R1
+ OH2
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MATERIALS AND METHODS 
Reagents and chemicals used:  
             Aniline derivatives(aniline,4-chloroaniline,4-bromo aniline, 4-
methoxyaniline, 3-methoxy  aniline, 4-nitroaniline ,3-nitroaniline,4-methylaniline, 
Phosphorous oxychloride, Dimethyl formamide, isoniazid,glacial acetic acid, Zn 
dust,methanol, 70%acetic acid  
            All the reagents and chemicals were procured from Sigma Aldrich High 
media and Lobachem. All the compounds procured were purified and dried, 
whenever necessary before use, following standard methods.  
Apparatus used:  
 Beakers, test tubes, glass rods, magnetic stirrer, thermometer, round 
bottom flask, reflux condenser, iodine flasks, watch glass, conical flasks, burette 
and pipettes.  
 
Analytical work:  
 Melting point was determined by using melting point apparatus MR-VIS, 
 visual melting range apparatus, LABINDIA and uncorrected.  
 Reactions were monitored by thin layer chromatography (TLC) on a pre- 
 coated silica gel G plated using Iodine vapor as visualizing agent.  
  UV spectra were recorded on JASCO V-530 UV-VIS spectrometer in the 
department of Pharmaceutical analysis, College of Pharmacy, SRIPMS, 
Coimbatore.  
 IR spectra were recorded on JASCO FTIR-420 series in the department of 
 Pharmaceutical Analysis, College of Pharmacy, SRIPMS, Coimbatore.  
 NMR spectra were recorded on Bruker AVANCE III 500MHz NMR 
 spectrometer at KAMARAJ UNIVERSITY MADURAI. 
  Mass spectra were recorded on JEOL GCMATE II GC-MS spectrometer 
 at SAIF, VIT VELLORE. 
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METHODOLOGY 
 
Step 1: Synthesis of acetanilides 
 (Aniline, 4-bromoaniline, 4-chloroaniline, 3-methoxyaniline, 4-
methoxyaniline,3-nitroaniline, 4-nitroaniline, 4-methylaniline were converted into 
their corresponding acetanilides) 
 A mixture of aniline and substituted anilines 0.11mol and Zn dust were 
added to acetic acid(30ml) in a 100ml round bottom flask, and heated over a 
gentle flame using water condenser. Heating was continued for about 2hrs.The 
reaction mixture was then carefully poured in cold water(100ml) in 250ml beaker 
with cooling and vigorous stirring. The shining crystals of their corresponding 
acetanilides were separated slowly. After 15mins the corresponding acetanilide 
crystals were collected by filtration. The solid crystals were washed over Buchner 
funnel with water and product was dried (yield 10g). It was crystallized in boiling 
water (if necessary charcoal may be used). 
 Acetanilide-90%yield,3-Methoxy acetanilide-95yield, 4-Methoxy 
acetanilide 90%yield, 4-chloroacetanilide-90%yield,4-bromoacetanilide-90% 
yield ,4-methyl acetanilide-80% yield,3-nitroacetanilide 50% yield, 4-
nitroacetanilide 60% yield 
 
Step 2: Synthesis of 2-chloro-3-formyl quinolines [1]                                          
            The compounds were prepared from acetanilide and corresponding 
substituted acetanilides under Vilsmeier - Haack reagent (POCl3/DMF). 
 To a solution of acetanilide and corresponding substituted acetanilides (5 
mmol) in dry DMF (15mmol) at 0-5 ͦ C with stirring POCl3 (60mmol) was added 
dropwise. The reaction mixture was stirred at 80-90 ͦ C for time ranging between 
4-16hr. This mixture was poured in crushed ice, stirred for 5 mins where 
corresponding 2-chloro-3-formyl quinolines formed was filtered, washed well 
with water and dried. The compounds were purified by recrystallization from 
either ethyl acetate or acetonitrile.  
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                2-chloro-3-formyl quinoline-70% yield,6-bromo- 2-chloro-3-formyl 
quinoline -80% yield,6-chloro 2-chloro-3-formyl quinolone-80% yield,7-
methoxy-2-chloro-3-formyl quinolone-90% yield, 6-methoxy-2-chloro-3-formyl 
quinolone-90% yield,7-nitro-2-chloro-3-formyl quinolone-40% yield ,6-nitro-2-
chloro-3-formyl quinolone-60% yield ,4-methyl-2-chloro-3-formyl quinolone-
60% yield. 
                              
Step 3: Synthesis of 3-formyl 2(H)quinolones:[1] 
                    A suspension of 2-chloro-3-formyl quinoline and substituted 2-
chloro-3-formyl quinolines  (1mmol) was dissolved in 70% CH3COOH(10ml) and  
heated under reflux for 4-6hrs.The completion of reaction was checked by 
TLC.Upon cooling the reaction mixture, corresponding 3-formyl-2- quinolones 
formed were precipitated, filtered, washed well with  water, dried and purified by 
recrystallization from DMF. 
                    3-formyl-2-quinolones-70%,6-bromo-3formyl-2-quinolones -80% 
yield, 6-bromo-3formyl-2-quinolones -80% yield,6-chloro-3formyl-2-quinolones -
80% yield,7-methoxy-3formyl-2-quinolones -80% yield,6-methoxy-3formyl-2-
quinolones -80% yield,7-nitro-3formyl-2-quinolones -60% yield,6-nitro-3formyl-
2-quinolones -60% yield, 6-methyl-3formyl-2-quinolones -80% yield. 
 
 Step 4: Synthesis of Schiff base from 3-formyl-2-quinolones [33] 
            Equimolar quantities of 3-formyl-2-quinolone and substituted  3-formyl-2-
quinolones (0.01mol) and isoniazid(0.01mol)  was dissolved in ethanol and 2-4 
drops conc.sulphuric acid was added and refluxed for 2-4hrs. It was then cooled 
and poured into crushed ice. Schiff bases of   corresponding  3-formyl-2-
quinolones thus  obtained were filtered, washed with water and recrystallised from 
ethanol. 
 3-formyl-2-quinolone Schiff base -77% yield,6-bromo- 3-formyl-2-
quinolone Schiff base -80% yield, 6-chloro- 3-formyl-2-quinolone Schiff base -
90% yield,7-methoxy- 3-formyl-2-quinolone Schiff base -90% yield,6-methyl- 3-
formyl-2-quinolone Schiff base -85% yield, 7-nitro- 3-formyl-2-quinolone Schiff 
base -50% yield, 6-nitro- 3-formyl-2-quinolone Schiff base -60% yield, 6-methyl-
3-formyl-2-quinolone Schiff base -85% yield, 
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NH2
R1
NHCOCH 3
R1
CH3COOH, Zn dust
reflux 3 hrs
NHCOCH 3
R1 R2
N
CHO
Cl
DMF / POCl 3
80
o
 - 90
o
C
R2
N
CHO
Cl
R2
N
H
CHO
O
70% CH3COOH
R2
N
H
CHO
O
+
N
CONHNH 2
N
R2
N
H
O
N
NH
C
O
3- or 4-substituted aniline 3- or 4-substituted acetanilide
3- or 4-substituted acetanilide 6- or 7-substituted-2-chloro 
quinoline-3-carbaldehyde  
6- or 7-substituted-2-chloro 
quinoline-3-carbaldehyde  
6- or 7-substituted-2-oxo-1,2-dihydro 
quinoline-3-carbaldehyde  
6- or 7-substituted-2-oxo-1,2-
dihydroquinoline-3-carbaldehyde  
pyridine-4-carbohydrazide
N-[6- or 7-substituted-(2-oxo-1,2-
dihydroquinoline-3-yl)methylidene]
pyridine-4-carbohydrazide
SCHEME
H
6-Br
6-Cl
7-OCH3
6-OCH3
7-NO2
6-NO2
6-CH3
R2R1
H 
4-Br
4-Cl
3-OCH3
4-OCH3
3-NO2
4-NO2
4-CH3
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PHYSICAL DATA CHARACTERIZATION 
C.C R1 R2 
MOLECULAR 
FORMULA 
MOLECULAR 
WEIGHT 
MP RF VALUE %YIELD 
5a H H C16H12N 4O2 292.2902 140.6 0.48 77 
5b 4-Br 6-Br C16H 11N 4O2 Br 371.188 148.9 0.7 80 
5c 4-Cl 6-Cl C16H11N 4O2Cl 326.7371 154.2 0.76 90 
5d 3-OCH3 7-OCH3 C17H14N4O3 322.3181 85.8 0.40 90 
5e 4 -OCH3 6-OCH3 C17H14N4O3 322.3181 89.4 0.42 85 
5f 3-NO2 7-NO2 C16H11N5O4 337.2902 119 0.74 50 
5g 4-NO2 6-NO2 C16H11N5O4 337.2902 123 0.75 60 
5h 4-CH3 6-CH3 C17H14N4O2 306.3187 145.2 0.52 85 
RECRYSTALLIZATION SOLVENT: ETHANOL 
SOLVENT SYSTEM USED: DIOXAN:ETHYLACETATE:WATER(9:1:1) 
VISUALIZING AGENT: IODINE VAPOUR 
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ANTIMICROBIAL STUDIES [74,75] 
 
Apparatus and chemicals required  
Sterile swab                    :  Hi Media  
Non-absorbent cotton     :  Rama Raju Surgical cotton Ltd.  
Conical flask                   :  Borosil  
Test tubes                        :  Borosil  
Petri dishes                      :  SD Fine-Chem Ltd.  
Micropipettes                  :  VARI pipettes (Hi-Tab Lab)  
Autoclave                        :  Universal Autoclave  
Laminar Air Flow unit    :  CLEAN AIR Instruments Inc.  
Microtips                         :  Tarsons  
 The antibacterial screening was carried out in the Pharmaceutical 
Biotechnology laboratory, College of Pharmacy, SRIPMS, Coimbatore.  
 
Media used  
 Nutrient media which is gelled with 2% agar (bacteriological grade) is 
used as the medium for the antibacterial screening.  
The nutrient media contains the following ingredients:-  
Nutrient broth             : 13g/l  
Agar                      :  15.00 g/l   
Final pH at 25°C            :  7.4(±0.2) 
Media preparation and sterilization   
 The ingredients were dissolved in distilled water with the aid of heat and 
the pH was adjusted to 7.4(±0.2) by using dilute acid or alkali.  
                   30-35 ml of nutrient media was transferred to Petri plates and sealed. 
The media is autoclaved at a pressure of 15 psi (121°C) for not less than 15 
minutes.           
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Microorganisms used 
  Staphylococcus aureus NCIM 2079, Bacillus subtilis NCIM 2063, 
Escherichia coli NCIM 2918 and Pseudomonas aeruginosa NCIM 2036 were 
procured from National Chemical Laboratory, Pune and stored in the 
Pharmaceutical Biotechnology laboratory, College of Pharmacy, SRIPMS, 
Coimbatore,Tamil Nadu. 
 
 • The strains were confirmed for their purity and identified by Gram’s 
 staining method and their characteristic biochemical reactions. 
 The selected strains were preserved by sub culturing them periodically on 
 nutrient agar slants and storing them under frozen conditions.  
 For antimicrobial study, fresh 24 hours  broth cultures were used after the 
 standardization of the culture.  
 
          Drugs used       :  5a-h(500μg/ml)  
 Standard drug  : Ofloxacin (200μg/ml)  
 Solvent             :  Dimethyl sulfoxide 
 
WORKING CONDITIONS IN LABORATORY  
          The entire work was done by using horizontal laminar flow hood so as to 
provide aseptic conditions. Before the commencement of the work, air sampling 
was carried out using a sterile nutrient agar plate and exposing it to the 
environment inside the hood. 
           After incubation, it was checked for the growth of microorganism and 
absence of growth confirmed aseptic working condition.  
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STANDARDIZATION OF INOCULUMS 
 All organisms were grown overnight (24 hours) at 37°C on nutrient agar 
 and harvested during the stationary growth phase.  
 Active cultures for experiments were prepared by transferring a loopful of 
cells from the stock culture to the test tubes containing nutrient media, 
incubated for 24 hours at 37°C.  
 Inoculum was standardized by matching the turbidity of the culture to 0.5 
McFarland standard. The standard was produced by mixing 0.05 ml of 
0.048 BaCl2 (1.175%w/v bariumchloridedehydrates) with 99.5 ml of 
0.36N H2SO4.  
 If the turbidity of the culture matches that of the McFarland standard, the 
 culture inoculating suspension has approximately 2.0×10.6CFU/ml of 
 bacteria.  
ANTI- BACTERIAL SCREENING BY KIRBY-BAUER METHOD  
 Nutrient media plates were prepared aseptically to get a thickness of  
5-6mm. The plates were allowed to solidify and inverted to prevent 
condensate falling on the agar surface. The plates were dried at 37°C 
before inoculation. The organisms were inoculated as per the following 
method in the plates prepared earlier. 
 The sterile swab was dipped in the previously standardized inoculum and 
excess of inoculums was removed by pressing and rotating the swab firmly 
against the sides of the culture tube above level of liquid. The swab was 
streaked all over the surface of the medium three times, rotating the plates 
through an angle of 60°C after each application. 
 Finally the swab was pressed round the edges of the agar surface. 
 The inoculation medium was allowed to dry at room temperature, with the 
 lid closed.  
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 The drug was poured in the wells, which are made with the help of a borer. 
And the measured quantity of the drug is poured with the help of the 
micro-pipette. Nearly 50μl of the solution is poured into the wells. The 
plates were kept in the refrigerator for 1 hour to facilitate the diffusion of 
the drugs. 
 Plates were prepared in triplicate and they were then incubated for 18-24 
 hours at 37°C.  
 After the incubation, the diameter of the zone of inhibition around the 
 drugs were measured and compared with that of the standard. 
 All the synthesized compounds were tested for antibacterial activity 
 against Gram positive and Gram negative bacteria. 
 Saturated solutions of the compounds were first studied and the 
compounds with zones of inhibition greater than 15mm were taken for 
quantitative studies. 
 
Screening of newly synthesized compound for antibacterial activity against 
gram-positive bacteria 
 Test drug           : Synthesized compounds 5a-h (500 μg/ml) 
 Standard drug    : Ofloxacin 200μg/ml 
 Solvent used      : Dimethyl sulfoxide 
 Blank solution   : Dimethyl sulfoxide 
 
 
 
 
 
 
 
ANTIBACTERIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA 
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COMPOUND CODE 
DIAMETER OF ZONE INHIBITION(mm) 
Staphylococcus aureus 
NCIM 2079 
Bacillus subtilus 
NCIM 2063, 
5a - - 
5b - 11 
5c 17 22 
5d - - 
5e - - 
5f - 18 
5g - 16 
5h - - 
Control - - 
std ofloxacin 32 39 
 
 (-)indicates no zone of inhibition 
 
 
 
 
 
 
 
 
   
 
 
 
 
Staphylococcus aureus 
NCIM 2079 
 
Bacillus subtilus 
NCIM 2063 
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Screening of newly synthesized compound for antibacterial activity against 
gram-negative bacteria 
Test drug          : Synthesized compounds 5a-h (500 μg/ml)  
Standard drug   : Ofloxacin 200μg/ml 
Solvent used     : Dimethyl sulfoxide 
Blank solution  : Dimethyl sulfoxide 
ANTIBACTERIAL ACTIVITY AGAINST GRAM-NEGATIVE  
BACTERIA 
COMPOUND CODE 
DIAMETER OF ZONE INHIBITION(mm) 
Escherichia coli NCIM 
2918 
Pseudomonas 
aeruginosa NCIM 2036 
5a - - 
5b 13 - 
5c 19 24 
5d - - 
5e - - 
5f 19 18 
5g 18 18 
5h 12 - 
Control - - 
Std ofloxacin 32 32 
(-) indicates no zone of inhibition 
  
 
 
 
 
 
 
Escherichia coli 
 NCIM 2918 
Pseudomonas aeruginosa 
NCIM 2036 
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SCREENING FOR ANTI-FUNGAL  Activity [78] 
MYGP MEDIA FOR CANDIDA ALBICANS 
Ingredients 
Malt extract powder   :  3g/l 
Yeast extract powder :  3g/l 
Dextrose                     :  10g/l 
Agar                            :  15g/l 
Water to make            :  100ml 
Final pH at 25oc          :  5.4±0.2 
POTATO DEXTROSE AGAR FOR ASPERGILLUS NIGER 
Ingredients 
Potato dextrose agar   :  39g/l 
Water to make            : 1000ml 
Preparation 
 The ingredients were dissolved in 1000ml of distilled water and boiled to 
dissolve the medium completely. 
Sterilization  
 15-30ml of MYGP MEDIA and Potato dextrose agar was transferred to 
petri plates and sealed. It was then autoclaved at pressure of 15psi (121˚c) for not 
less than 15mins. 
Organism used 
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 Candida albicans NCIM 3100 and Aspergillus niger NCIM 596 
Drugs used              : synthesized drugs 5a-h(500mg/ml) 
Standard drugs        : fluconazole (200µg/ml) 
Solvent                    : Dimethyl sulfoxide 
ANTI-FUNGAL SCREENING BY KIRBY-BAUER METHOD 
 MYGP MEDIA and POTATO DEXTROSE AGAR plates were 
prepared aseptically to get a thickness of 5-6mm. The plates were allowed 
to solidify and inverted to prevent condensate falling on the agar surface. 
The plates were dried at 37°C before inoculation. 
  The organisms (Candida albicansNCIM3100 and Aspergillus niger 
NCIM596) were inoculated as per the following method in the plates 
prepared earlier, by dipping a sterile swab in the previous standardized 
inculums was removed by pressing and rotating the swab firmly against 
the sides of the culture tube above the level of liquid and finally streaking 
the swab all over the surface of the medium three times,rotating the plates 
through an angle of 60˚after each application. 
 Finally the swab was pressed around the edges of agar surface.It was 
 allowed to dry at room temperature, with the lid closed. 
 The sterile disc containing test drugs,standard and blank were placed on 
the previously inoculated surface of MYGP MEDIA  and POTATO 
DEXTROSE AGAR plates.The plates were kept in the refrigerator for 1 
hour to facilitate the diffusion of th drugs. 
 Plates were prepared in triplicate and they were incubated for 18-24hours 
 at 37˚c. 
 After the incubation ,the diameter of the zone of inhibition around the 
 drugs were measured and compared with that of standard. 
 All the synthesized compounds were tested for antifungal activity against 
 Candida albians and Aspergillus niger. 
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 Saturated solutions of compounds were  studied and the compounds with 
zone of inhibition greater than 15mm were taken for quantitative studies. 
Screening of newly synthesized compound for antibacterial activity against 
gram-positive bacteria 
Test drug           : Synthesized compounds 5a-h (500 μg/ml) 
Standard drug    : Flucanazole 200μg/ml 
Solvent used      : Dimethyl sulfoxide 
Blank solution   : Dimethyl sulfoxide 
 
COMPOUND CODE 
Diameter of zone of inhibition(mm) 
Candida albicans 
NCIM3102 
Aspergillus niger 
NCIM596 
        5a           -           - 
        5b           23           - 
        5c           27           14 
        5d           -           - 
        5g           -           - 
        5f           22           22 
        5g           20           15 
        5h            -            - 
        Control            -            - 
        Std fluconazole           30           32 
(-)indicates no zone of inhibition 
          
 
ANTIMYCOBACTERIAL  STUDIES[79] 
 
Aspergillus niger NCIM596 Candida albicans NCIM3102 
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Conventional agar diffusion technique for susceptibility tests, which rely 
on the size of zone of inhibition surrounding a drug containing disc are not 
suitable for the slowly growing Mycobacterium species because the drug diffuses 
throughout the medium before the organism has the chance to grow. So, the 
following principles are recognized for the antimycobacterial screening.  
 
 The composition of medium should have a minimal effect on drug 
 inactivation. So, Middle Brook 7H9 broth base is used.  
 Drug containing medium should be stored in a refrigerator shielded from 
light and kept in plastic tubes tightly closed in order to protect them from 
evaporation.  
 Homogenization of inoculum is essential to eliminate large clumps of 
 cells.  
SUSCEPTIBILITY TESTING 
 This is done by two methods: 
 Direct method 
 Indirect method 
Direct method 
 This was done if acid-fast bacilli are seen on the smear of the concentrated 
clinical specimen. Dilutions are made and inoculated. 
Indirect method 
            In this method, bacterial mass is suspended in Middle Brook 7H9 broth 
containing these or four small sterile glass beads. Mixture is placed on a vortex 
mixer and precautions are taken to prevent aerosol production. Tube is allowed to 
stand for 15 min. The stock suspensions are diluted and 0.1 ml is inoculated into 
control and drug containing media. 
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            The antimycobacterial screening was carried out in Maratha Mandal NGH 
Institute of Dental Sciences and Research Center, Belgaum,Karnataka 
ANTITUBERCULAR SCREENING BY MICROPLATE ALAMAR BLUE 
ASSAY (MABA)[79] 
  Alamar Blue is a cell viability assay reagent which contains the cell 
permeable, non-toxic and weakly fluorescent blue indicator dye called resazurin. 
It is an oxidation-reduction indicator used for the screening of cell growth, 
particularly in various cell toxicity studies. The dye changes its colour from blue 
to pink and becomes fluorescent, when reduced to resorufin by oxidoreductases 
within viable cells 
N
+
ONaO O
O(-)
N
O
O
NaO
resazurin(oxidised)                                                       resorufin(reduced) 
             
 Alamar Blue is used for the screening of antitubercular activity. Since 
Mycobacterium is an aerobic organism, its presence of growth turns Alamar Blue 
to pink colour. Hence, pink colour indicates the presence of growth (no 
antitubercular activity) and blue colour indicates the absence of growth (inhibitory 
activity of agents tested).  
 
Procedure  
1)  The antimycobacterial activity of compounds were assessed against M. 
 tuberculosis using Microplate Alamar Blue Assay (MABA).  
2)  This methodology is non-toxic, uses a thermally stable reagent and shows 
good correlation with proportional and BACTEC radiometric method. To 
the outer perimeter of sterile 96 wells plates, 200μl of sterile deionized 
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water was added to minimize evaporation of medium in the test wells 
during incubation.  
4)  The 96 wells plates received 100 μl of the Middlebrook 7H9 broth 
 (inoculated with Mycobacterium tuberculosis of H37RV Strain) and serial 
 dilution of compounds were made directly on plate.  
5)  The final drug concentrations tested were 100 to 0.2 μg/ml.  
6)  Plates were covered and sealed with parafilm and incubated at 37ºC for 
 five days.  
7)  After this time, 25μl of freshly prepared 1:1 mixture of Alamar Blue 
reagent and 10% tween 80 was added to the plate and incubated for 24 hrs.  
8)  A blue color in the well was interpreted as no bacterial growth, and pink 
 color was scored as growth.  
9)  The MIC was defined as the lowest drug concentration which prevented 
 the color change from blue to pink. 
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RESULTS AND DISCUSSION  
               The synthesized compounds were evaluated for in-vitro 
antimycobacterial activity by Alamar Blue assay method and the results are shown 
in table . 
S.NO 
COMPOUND 
CODE 
100 
µg/ml 
50 
μg/ml 
25 
μg/ml 
12.5 
μg/ml 
6.25 
μg/ml 
3.12 
μg/ml 
1.6 
μg/ml 
0.8 
μg/ml 
1 5a S S S S S R R R 
2 5b S S S S S R R R 
3 5c S S S S S S R R 
4 5d R R R R R R R R 
5 5e R R R R R R R R 
6 5f S S S S S R R R 
7 5g S S S S S R R R 
8 5h R R R R R R R R 
9 
Pyrazinamide 
(std)) 
S S S S S S R R 
10 
Streptomycin 
(std) 
S S S S S S R R 
11 
Ciprofloxacin 
(std) 
S S S S S R R R 
 
S- Sensitive  R- Resistant 
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SPECTRAL CHARACTERIZATION DATA [71-73] 
 The structures of synthesized compounds during the present investigation 
were established on the basis of chemical d IR, UV, NMR and MASS spectral 
data. The purity of the compounds were established by single spot on TLC plates. 
                                         Compound code-5a 
                                       
N
H
O
N
NH O
N
H
 
Chemical name  
N'-[(2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
UV spectrum 
Solvent used :METHANOL 
ʎ max              :270nm 
IR (KBr,vmax in cm
-1) 
C=0 (ketone) -1608,C=O(amido)-1666 
C=N -1540 
N-N  -1009 
N-N=C -3312 
C-H (AROMATIC) -2937 
C=C(aromatic) -1448 
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Compound code-5b 
                                               
N
H
O
N
NH O
N
Br
 
Chemical name  N'-[(6-bromo-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
UV spectrum Solvent used :METHANOL 
ʎ max              :255nm 
IR (KBr,vmax in cm
-1) C=0(ketone)  -1671,C=O (amido)-1604 
C=N -1536 
N-N  -1005 
N-N=C -3300 
C-Br  -691 
C=C (aromatic)-1488 
NMR 1H NMR                             13C NMR  
CH=N  -8.55                        quinoline- 125 
C5 pyridine -7.61                 C=N  -148 
C8 quinoline -7.79               pyridine  128 
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MASS SPECTRAL DATA 
Molecular weight of the compound : 372 
M+1 peak =373 
Sl. No. Fragments m/z values 
1 
N
H
O
N
NH O
N
Br
 
372 
2 
N
H
O
Br CH3
 
238 
3 
N
H
O
 
145 
4 
 
 
N
ONH2
 
 
122 
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MASS SPECTRA 
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 1H NMR 
1311
                                                                   13C NMR 
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                                         Compound code-5c 
                                                
N
H
O
N
NH O
N
Cl
 
Chemical name 
N'-[(6-chloro-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
 
UV spectrum 
Solvent used :METHANOL 
ʎ max              :252nm 
IR (KBr,vmax in cm
-1) 
C=0 (ketone) -1664, C=O (amido)-1607 
C=N -1540 
N-N  -1040 
N-N=C -3285 
C-Cl -751 
C=C (aromatic)-1393 
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                                          Compound code-5d                                                                                                  
                                      
N
H
O
N
NH O
N
O
CH3
 
Chemical name 
N'-[(Z)-(7-methoxy-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
UV spectrum 
Solvent used :METHANOL 
ʎ max              :277nm 
IR (KBr,vmax in cm
-1) 
C=0(ketone)  -1635, C=O (amido)-1601 
C=N -1601 
N-N  -1141 
N-N=C -3312 
C-OCH3  -1121 
C=C (ar)-1450 
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                                                Compound code-5e 
                                      
N
H
O
N
NH O
N
OCH3
 
Chemical name N'-[(6-methoxy-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
 
UV spectrum Solvent used :METHANOL 
ʎ max              :272nm 
IR (KBr,vmax in cm
-1) C=0(ketone)  -1635,  
C=N -1601 
C-N (Ar) -1421 
N-N=C -3306 
C-OCH3  -1121 
C=C (aromatic)-1449 
NMR 
 
 
1H NMR                             13C NMR  
CH=N  -8.55                        quinoline- 127 
C5 pyridine -7.31                 C=N  -148 
C8 quinoline -7.79               pyridine  40 
 
Molecular weight of the compound : 372 
S.No Fragments M/z values 
1 
N
H
O
N
NH O
N
O
CH3
 
322 
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2 
N
H
O
O
CH3
CH3
 
189 
3 
N
H
O
O
CH3
 
175 
4 
N
ONH2
 
122 
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 MASS SPECTRA 
 
1H NMR  
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13C NMR 
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Compound code-5f 
                                           
N
H
O
N
NH O
N
O2N
 
Chemical name N'-[(7-nitro-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
 
UV spectrum Solvent used :METHANOL 
ʎ max              :370nm 
IR (KBr,vmax in cm
-1) C=0(ketone)  -1632, C=O (amido)-1599 
C=N -1505 
N-N  -1114 
N-N=C -3340 
N-O -1471 
C=C (aromatic-1444 
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Compound code-5g 
Spectral Characterization Data 
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N
H
O
N
NH O
N
O2N
 
Chemical name N'-[(6-nitro-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
UV spectrum Solvent used :METHANOL 
ʎ max              :370nm 
IR (KBr,vmax in cm
-1) C=0 (ketone) -1599, C=O (amido)-1632 
C=N -1471 
N-N  -1114 
N-N=C -3352 
N-O -1471 
C=C (aromatic)-1444 
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                                                Compound code-5h 
N
H
O
N
NH O
N
CH3
 
Chemical name N'-[(6-methyl-2-oxo-1,2-dihydroquinolin-3-
yl)methylidene]pyridine-4-carbohydrazide 
UV spectrum Solvent used :METHANOL 
ʎ max              :277nm 
IR (KBr,vmax in cm
-1) C=0(ketone)  -1602, C=O  
C=N -1382 
N-N  -1120 
N-N=C -3426 
C-CH3 -2921 
C=C(aromatic)  -1384 
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RESULT AND DISCUSSION 
Antimycobacterial activity 
 All the newly synthesized compounds were screened for their 
antimycobacterial activity against Mycobacterium tuberculosis of H37RV Strain  
Using pyrazinamide 3.125 µg/ml,streptomycin 6.125 µg/ml and ciprofloxacin 
3.125µg/ml as standards. 
            Three of the newly synthesized compounds  5d,5e,5h were resistant and 
showed no activity ,where  five  of  the newly synthesized compounds 
5a,5b,5c,5f,5g showed  potent antimycobacterial activity by inhibiting the growth 
at concentration of 6.25μg/ml .Compound 5c exhibited the highest activity by 
inhibiting the growth  at concentration 3.125μg/ml. 
Antibacterial activity 
 All the newly synthesized compounds were screened for their antibacterial 
activity against both Gram positive and Gram negative organisms using Ofloxacin 
(500µ/ml) as the standard. 
            The newly synthesized compound 5a,5c,5d,5e,5f,5g,5h were resistant and 
compound 5c was moderately sensitive against the test microorganism 
Staphylococcus aureus NCIM 2079 at 500µg/ml concentration.  The compound 5c 
exhibited the highest activity. 
 The compounds 5a,5d,5e,5h were resistant and compound  5b was 
moderately sensitive and compounds 5c,5f,5g were sensitive against the test 
microorganism Bacillus subtilis NCIM 2063 at 500µg/ml concentration.  The 
compound 5c exhibited the highest activity. 
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 The compounds 5a,5b,5d,5e,5h were resistant and  compounds  5c,5f,5g  
were sensitive against the test microorganism Pseudomonas aeruginosa NCIM 
2036 at 500µg/ml concentration.  The compound 5c exhibited the highest activity. 
            The compounds 5a,5d,5e were resistant and  compound 5h was moderately 
sensitive and compounds  5c,5f,5g  were sensitive against the test microorganism 
Escherichia coli NCIM 2918 at 500µg/ml concentration.  The compound 5c,5f 
exhibited the highest activity. 
Antifungal activity 
            All the newly synthesized compounds were screened for their antifungal 
activity against  Candida albicans NCIM 3100 and Aspergilus niger NCIM 596 
by agar disc diffusion method using Flucanazole 10µg/disc  as the standard. 
10µg/disc  was used for all the test compounds. 
 The compounds  5a,5d,5e,5h were resistant and compounds  5b,5c,5f,5g  
were sensitive against the test microorganism Candida albicans NCIM 3100 at 
100µg/disc concentration.  The compound 5c exhibited the highest activity 
 he compounds 5a,5b,5d,5e,5h were resistant compounds  5c,5f,5g  were 
moderately sensitive against the test microorganism Aspergilus niger NCIM 596 
at 100µg/disc concentration.  The compound 5c,5f exhibited the highest activity. 
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SUMMARY AND CONCLUSION 
      With the view of synthesizing new compounds with minimum side effects, 
less toxicity, non-resistant and more selective against disease-producing 
microorganisms, the present work was undertaken to synthesize 8 different Schiff 
bases of 3-formyl-2-quinolone and substitutes of 3-formyl-2-quinolones with 
isoniazid. 
LITERATURE REVIEW 
      The extensive literature reports showed that the  Schiff  bases of 3-formyl- 
2- quinolones   are potent antimicrobial agents.  The 2-Quinolone moiety and 
Schiff  bases posses excellent antimicrobial activity. 
SCHEME 
      All the intermediate and final compounds are synthesized by traditional 
method. 
STEP 1: 
 Initially Acetanilde and substituted acetanilides  were prepared  by 
refluxing aniline and substituted anilies  with acetic acid and zinc dust.  
STEP 2: 
 2-chloro-3-formyl quinoline and substituted  2-chloro-3-formyl quinolines 
were synthesized from acetanilide and substituted acetanilides correspondingly  
using Vilsmeier Haack reaction. 
STEP3: 
 The synthesized compounds  were  refluxed with a 70%  acetic acid to 
give  3-formyl-2-quinolone and substituted 3-formyl-2-quinolones 
Summary & Conclusion 
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STEP4: 
 Finally, 3-formyl-2-quinolone and substituted 3-formyl-2-quinolones  
were refluxed with isoniazid in presence of ethanol and concentrated sulphuric 
acid to get different Schiff bases. 
SPECTRAL STUDIES 
 Structures of all the newly synthesized compounds were confired by 
UV,IR,  MASS and NMR. 
 
A)  Antimycobacterial activity  
            Antitubercular screening of the synthesized compounds were done by 
Alamar Blue assay method in Middlebrook 7H9 broth against Mycobacterium 
tuberculosis H37RV strain (ATCC No. 27294). Four of newly synthesized 
compounds 5a,5b,5f,5g showed antimycobacterial activity by inhibiting the 
growth at concentration of 6.25μg/ml ,where compound 5c inhibited the growth at 
concentration of 3.125μg/ml .other three newly synthesized compounds were 
resistant and showed no activity. 
 
B)  Antibacterial screening 
 The synthesized compounds were screened for antibacterial activity 
against both gram positive (Staphylococcus aureus NCIM 2079 and Bacillus 
subtilis NCIM 2063) and gram negative (Escherichia coli NCIM 2911 and 
Pseudomonas aeruginosa NCIM 2036) organisms by Kirby-Bauer method. Three 
of eight   compounds were found to be sensitive active against bacteria. 5c,5f,5g  
were found to be sensitive  activity against Gram positive bacteria and  Gram 
negative bacteria. 
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C) Antifungal screening 
 All the newly synthesized compounds were screened for antifungal 
activity Candida albicans NCIM 3100 and Aspergillus niger NCIM 596 by agar 
diffusion method using Flucanazole(10µg/disc) as the standard.  100µg/disc was 
used for all the test compounds. 
      The compounds 5b, 5c, 5f, 5g exhibited the highest activity towards 
Candida albicans. 
CONCLUSION 
        Based on the results of synthetic works, characterization data, 
antimicrobial screening and antimycobacterial screening the following 
conclusions were made. 
 Using the schemes evolved, eight different Schiff bases of 3-formyl-2-
quinolone and substituted 3-formyl-2-quinolones  were synthesized in 
good yields. 
 Four synthesized derivatives (5a,5b,5f,5g) showed equipotent 
antitubercular activity compared to the standard streptomycin at 
concentration of 6.12μg/ml. Compound 5c showed equipotent 
antitubercular activity compared to the standards Pyrazinamide and 
Ciprofloxacin  at concentration of 3.125μg/ml 
 The synthesized compounds showed poor to moderate antibacterial 
 activity. 
  The in vitro antimicrobial studies showed that three of eight compounds 
exhibited good antibacterial activity in which compound 5c showed the highest 
activity against Bacillus subtillis NCIM 2063 and Pseudomonas aeruginosa  
NCIM 2036. The compounds 5b,5c,5f,5g exhibited the highest antifungal 
activities. 
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 Among the synthesized compounds 5b,5c,5f,5g  can be taken as the lead 
 molecule and acute toxicity studies are to be done on these promising 
compounds.  
5b 
                        
N
H
O
N
NH O
N
Br
 
5c 
                             
N
H
O
N
NH O
N
Cl
 
    5f 
N
H
O
N
NH O
N
O2N
 
5g 
                          
N
H
O
N
NH O
N
O2N
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LIST OF NEWLY SYNTHESIED DRUGS 
COMPOUND 
CODE 
IUPAC NAME STRUCTURE 
 
 
5a 
N'-[(2-oxo-1,2-
dihydroquinolin-3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
 
N
H
O
N
NH O
N
H
 
 
 
5b 
N'-[(6-bromo-2-oxo-
1,2-dihydroquinolin-
3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
N
H
O
N
NH O
N
Br
 
 
 
5c 
N'-[(6-chloro-2-oxo-
1,2-dihydroquinolin-
3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
 
N
H
O
N
NH O
N
Cl
 
 
 
 
5d 
N'-[(7-methoxy-2-
oxo-1,2-
dihydroquinolin-3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
 
N
H
O
N
NH O
N
O
CH3
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5e 
N'-[(8-methoxy-2-
oxo-1,2-
dihydroquinolin-3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
 
 
N
H
O
N
NH O
N
OCH3
 
 
 
 
5f 
N'-[(7-nitro-2-oxo-
1,2-dihydroquinolin-
3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
 
N
H
O
N
NH O
N
O2N
 
 
 
5g 
N'-[(6-nitro-2-oxo-
1,2-dihydroquinolin-
3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
N
H
O
N
NH O
N
O2N
 
 
 
5h 
N'-[(6-methyl-2-oxo-
1,2-dihydroquinolin-
3-
yl)methylidene]pyridi
ne-4-carbohydrazide 
 
N
H
O
N
NH O
N
CH3
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